Discovery and preclinical evaluations of WX-0593, a novel ALK inhibitor targeting crizotinib-resistant mutations.
Liu X, Zhang L, Wan H, Zhu Z, Jin J, Qin Y, Mao W, Yan K, Fang D, Jiang W, Hu L, Chen J, Chen K, Chen S, Li J, Zhao S, Zheng S, Zhang L, Ding CZ.
Liu X, et al. Among authors: zhang l.
Bioorg Med Chem Lett. 2022 Jun 15;66:128730. doi: 10.1016/j.bmcl.2022.128730. Epub 2022 Apr 11.
Bioorg Med Chem Lett. 2022.
PMID: 35421578